Document is current
Any future updates will be listed below
-
Authors
Held, Jana
Supan, Christian
Salazar, Carmen L. Ospina
Tinto, Halidou
Bonkian, Léa Nadège
Nahum, Alain
Sié, Ali
Abdulla, Salim
Cantalloube, Cathy
Djeriou, Elhadj
Bouyou-Akotet, Marielle
Ogutu, Bernhards
Mordmüller, Benjamin
Kreidenweiss, Andrea
Siribie, Mohamadou
Sirima, Sodiomon B.
Kremsner, Peter G.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00739206 at ClinicalTrials.govnct01445938 at ClinicalTrials.govDocuments that mention this clinical trial
SAFETY AND EFFICACY OF SAR97276A FOR TREATING MALARIA: TWO OPEN-LABEL MULTICENTER PHASE II CLINICAL STUDIES IN AFRICAN CHILDREN AND ADULTS
https://doi.org/10.1136/bmjgh-2016-000260.58
Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients
https://doi.org/10.1186/s12936-017-1832-x
Documents that mention this clinical trial
SAFETY AND EFFICACY OF SAR97276A FOR TREATING MALARIA: TWO OPEN-LABEL MULTICENTER PHASE II CLINICAL STUDIES IN AFRICAN CHILDREN AND ADULTS
https://doi.org/10.1136/bmjgh-2016-000260.58
Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients
https://doi.org/10.1186/s12936-017-1832-x
-
Funding
Funding for this research was provided by:
Sanofi
- License Information
-
More Information
Article History
Received: 30 January 2017
Accepted: 23 April 2017
First Online: 4 May 2017
